STOCK TITAN

MKT Capital Thanks Fellow Shareholders for Their Strong Support at Aurinia’s 2023 Annual Meeting

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Highlights Aurinia Chairman George Milne and Compensation Committee Chair Joseph Hagan Received Less Than Majority Support from Shareholders, Resulting in Their Resignations from the Board

Notes the Company’s Executive Compensation Proposal Did Not Receive Majority Support and Its Proposed Amendment to the Equity Incentive Plan Was Not Approved by Shareholders

Appreciates Shareholders for Providing a Clear Mandate for Change at This Year’s Annual Meeting and Urges the Board to Publicly Commit to a Strategic Review Process

CAYMAN ISLANDS--(BUSINESS WIRE)-- MKT Capital Ltd. (together with its affiliates, “MKT Capital” or “we”), a significant shareholder of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”) with beneficial ownership of approximately 4.2% of Aurinia’s outstanding shares, today commented on the outcome of the Company’s 2023 Annual General Meeting of Shareholders (the “Annual Meeting”) held on May 17, 2023. At the Annual Meeting, Chairman George Milne and Compensation Committee Chair Joseph Hagan received less than majority support from shareholders and have subsequently submitted their resignations to the Board of Directors (the “Board”), pursuant to the Company’s Majority Voting Policy. Additionally, the Company’s non-binding advisory vote on executive compensation did not receive majority support and the proposed amendment to the equity incentive plan was not approved.

Antoine Khalife, founder of MKT Capital, commented:

“We appreciate that our fellow shareholders considered MKT Capital’s views and ultimately sent a clear message to Aurinia at this year’s Annual Meeting. Now that Messrs. Milne and Hagan have submitted their respective resignations, we expect the Board to respect the will of shareholders by promptly accepting these resignations and commencing a strategic review process. We are pleased that shareholders have sent a clear mandate for change – today’s vote outcome demonstrates others clearly share our concerns with the Board’s historic unwillingness to act on shareholder feedback. We hope that this trend stops now and expect the Board to finally heed shareholder feedback by publicly committing to a strategic review process, which we believe is the best path forward for all Aurinia stakeholders. We will continue to monitor the Company’s leadership and their actions closely and will take all necessary steps to reconstitute the Board further, if we deem it necessary, to ensure that shareholders’ interests are appropriately represented in the boardroom.”

***

About MKT Capital Ltd.

Founded in 2012 by Antoine Khalife, MKT Capital Ltd. is an investment management firm which aims to deliver optimal risk-adjusted returns for its investors. For more information, contact Info@mkttacticalfund.com.

THIS IS NOT A SOLICITATION OF AUTHORITY TO VOTE YOUR PROXY. DO NOT SEND US YOUR PROXY CARD. MKT CAPITAL LTD. IS NOT ASKING FOR YOUR PROXY CARD AND WILL NOT ACCEPT PROXY CARDS IF SENT. MKT CAPITAL LTD. IS NOT ABLE TO VOTE YOUR PROXY, NOR DOES THIS COMMUNICATION CONTEMPLATE SUCH AN EVENT.

Longacre Square Partners

Charlotte Kiaie / Olivia McCann, 646-386-0091

ckiaie@longacresquare.com / omccann@longacresquare.com

Source: MKT Capital Ltd.

Aurinia Pharmaceuticals Inc

NASDAQ:AUPH

AUPH Rankings

AUPH Latest News

AUPH Stock Data

1.30B
132.45M
7.21%
42.72%
4.8%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
EDMONTON